The renal cell carcinoma lysis by a specific cytotoxic T cell clone is independent of the Fas/Fas-L cytotoxic pathway

Tissue Antigens

Volumn 48, Issue 4 I, 1996, Pages 295-300

  Caignard, A ^a   Guillard, M ^a   Cai, Z ^a   Asselin Paturel, C ^a   Carayol, G ^a   Chouaib, S ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Cytotoxic T lymphocytes; Fas APO 1; Fas Fas L cytotoxic pathway; Renal cell carcinoma

Indexed keywords

ANTIBODY; CALCIUM ION; EGTAZIC ACID; FAS ANTIGEN; MESSENGER RNA;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; LYMPHOCYTE CLONE; PRIORITY JOURNAL; PROTEIN INDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0029860607     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1996.tb02648.x     Document Type: Article

References (22)

1. Tschopp J, Nabholz M. Perforin-mediated target cell lysis by cytotolytic T lymphocytes. Annu Rev Immunol 1990: 8: 279-305.
2. Heusel JW, Wesselschmidt RL, Shresta S, Russell JH, Ley TJ. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 1994: 76: 977-89.
3. Kagi D, Vignaux F, Ledermann B et al. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994: 265: 528-530
4. Itoh N, Ynehara S, Ishii A et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991: 66: 233-243.
5. Oehm A, Behrmann I, Falk W et al. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem 1992: 267: 10709-715.
6. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993: 75: 1169-78.
7. 2+ independent T cell mediated cytotoxicity. J Exp Med 1993: 177: 195-200.
8. Vignaux F, Vivier E, Malissen B, Depraetere V, Nagata S, Golstein P. TCR/CD3 coupling to Fas-based cytotoxicity. J Exp Med 1995: 181: 781-91.
9. Trauth BC, Klas C, Peters AMJ et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989: 245: 301-305.
10. Leithauser F, Dhein J, Mechsheimer G et al. Constitutive and induced expression of APO-1, a member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 1993: 69: 415-429.
11. Caignard A, Guillard M, Gaudin C, Escudier B, Triebel F, Dietrich PY. In situ demonstration of renal cell carcinoma specific T cell clones. Int J Cancer 1996: 66: 564-570.
12. Cheng J, Zhou T, Shapiro JP et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994: 263: 1759-62.
13. Palmer PA, Vinke J, Evers P et al. Continuous infusion of recombinanat interlukin-2 with or without autologous activated killer cells for the treatment of advanced renal cell carcinoma. Eur J Cancer 1992: 28A: 1038-44.
14. Owen-Schaub LB, Meterissian S, Ford RJ. Fas-APO-1 expression and function on malignant cells of hematologic and nonhematologic origin. J Immunother 1993: 14: 234-241.
15. Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y, Fontana A. Anti-Fas/APO-1 antibody mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J Clin Invest 1994: 94: 954-964.
16. Owen-Schaub LB, Angelo LS, Radinsky R, Ware CF, Gesner TG, Bartos DP. Soluble Fas/Apo-1 in tumor cells: a potential regulator of apoptosis? Cancer Lett 1995: 94: 1-8.
17. Ju ST, Cui H, Pank DJ, Ettinger R, Marshak-Rothstein A. Participation of target Fas in apoptosis pathway induced by CD4+ Th1 and CD8+ cytotoxic effectors cells. Proc Natl Acad Sci U S A 1994: 91: 4185-4190.
18. Lowin B, Hahne M, Mattmann C, Tschopp J. Cytolytic T cell cytotoxicity is mediated through perform and Fas lytic pathways. Nature (Lond) 1994: 370: 650-652.
19. Lowin B, Mattman C, Hahne M, Tschopp J. Comparison of Fas(Apo/1CD95) and perforin-mediated cytotoxicity in primary T lymphocytes. Int Immunol 1996: 8: 57-63.
20. Mami-Chouaib F, Flament C, Asselin-Paturel C, Gaudin C, Chouaib S. TCR alpha/beta and TCR gamma/delta CD4-/ CD8+ HLA-DR alloreactive CTL clones do not use Fas/ Fas ligand pathway to lyse their specific target. Hum Immunol (in press).
21. Glass A, Walsh CM, Lynch DH, Clark WR. Regulation of the Fas lytic pathway in cloned CTL. J. Immunol 1996: 156: 3638-3644.
22. Kagi D, Lederman B, Burki K et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature (Lond) 1994: 369: 31-36.